Related Experiment Videos
Serum free carnitine levels in children with recurrent pulmonary infections
A Törel Ergür1, F Tanzer, O Cetinkaya
1Department of Pediatrics, Faculty of Medicine, Cumhuriyet University, Sivas, Turkey.
Insights
Children with recurrent pulmonary infections have lower serum free carnitine levels. Supplementation with L-carnitine may benefit these pediatric patients, improving their health outcomes.
Area of Science:
- Biochemistry
- Pediatrics
- Pulmonology
Background:
- Recurrent pulmonary infections are a significant health concern in children.
- Carnitine plays a vital role in cellular energy metabolism.
- Previous research suggests potential links between carnitine deficiency and certain chronic conditions.
Purpose of the Study:
- To investigate serum free carnitine levels in children experiencing recurrent pulmonary infections.
- To compare these levels with those of healthy children.
- To explore the potential therapeutic role of L-carnitine in this pediatric population.
Main Methods:
- Serum samples were collected from 33 children with recurrent pulmonary infections and 30 healthy controls.
- Free carnitine levels were quantified using established biochemical assays.
- Statistical analysis was performed to compare mean levels between the groups.
Main Results:
- Children with recurrent pulmonary infections exhibited significantly lower average serum free carnitine levels (26.12 +/- 0.98 nmol/mL) compared to healthy controls (38.98 +/- 0.79 nmol/mL).
- The difference in mean free carnitine levels was statistically significant (P < 0.01).
Conclusions:
- Reduced serum free carnitine is associated with recurrent pulmonary infections in children.
- Oral L-carnitine supplementation is recommended as a potential therapy for pediatric patients suffering from recurrent pulmonary infections.
Abstract:
The serum free carnitine levels of 33 children with recurrent pulmonary infection and 30 healthy children were measured and found to be 26.12 +/- 0.98 nmol/mL and that of the control group 38.98 +/- 0.79 nmol/mL on the average. The mean free carnitine level was statistically determined to be significantly lower when compared with that of the control group (P < 0.01). The results indicate that oral L-carnitine therapy is recommended for pediatric patients with recurrent pulmonary infection.